{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:50:52Z","timestamp":1767135052513,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd009684","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T00:00:00Z","timestamp":1503532800000}}],"reference-count":58,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T00:00:00Z","timestamp":1503532800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T00:00:00Z","timestamp":1503532800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009684.pub2","type":"journal-article","created":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T08:51:45Z","timestamp":1503564705000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Zonisamide for essential tremor"],"prefix":"10.1002","volume":"2017","author":[{"given":"Elisa","family":"Bruno","sequence":"first","affiliation":[{"name":"University of Catania; Department GF Ingrassia, Section of Neurosciences; Catania Italy 95123"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Nicoletti","sequence":"additional","affiliation":[{"name":"University of Catania; Department GF Ingrassia, Section of Neurosciences; Catania Italy 95123"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graziella","family":"Filippini","sequence":"additional","affiliation":[{"name":"Fondazione IRCCS, Istituto Neurologico Carlo Besta; Scientific Direction; via Celoria, 11 Milan Italy 20133"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graziella","family":"Quattrocchi","sequence":"additional","affiliation":[{"name":"University of Catania; Department GF Ingrassia, Section of Neurosciences; Catania Italy 95123"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Colosimo","sequence":"additional","affiliation":[{"name":"Terni University Hospital; Department of Neurology; Terni Italy 05100"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Zappia","sequence":"additional","affiliation":[{"name":"University of Catania; Department GF Ingrassia, Section of Neurosciences; Catania Italy 95123"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,8,24]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD009684.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/mds.21282","article-title":"A double-blind placebo-controlled trial of zonisamide (Zonegran) in the treatment of essential tremor","volume":"22","author":"Zesiewicz","year":"2006","journal-title":"Movement Disorders"},{"issue":"14","key":"10.1002\/14651858.CD009684.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1002\/mds.21717","article-title":"Zonisamide in patients with essential tremor and Parkinson's disease","volume":"22","author":"Bermejo","year":"2007","journal-title":"Movement Disorders"},{"issue":"3","key":"10.1002\/14651858.CD009684.pub2-BIB0003|cit3","first-page":"139","article-title":"Zonisamide in refractory essential tremor","volume":"46","author":"Bermejo","year":"2008","journal-title":"Revista de Neurologia"},{"issue":"3","key":"10.1002\/14651858.CD009684.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/mds.22418","article-title":"Zonisamide for essential tremor: an evaluator-blinded study","volume":"24","author":"Handforth","year":"2009","journal-title":"Movement Disorders"},{"issue":"6","key":"10.1002\/14651858.CD009684.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/WNF.0b013e318074dd4f","article-title":"Zonisamide for essential tremor","volume":"30","author":"Ondo","year":"2007","journal-title":"Clinical Neuropharmacology"},{"issue":"2","key":"10.1002\/14651858.CD009684.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.parkreldis.2004.09.004","article-title":"Effect of zonisamide on essential tremor: a pilot crossover study in comparison with arotinolol","volume":"11","author":"Morita","year":"2005","journal-title":"Parkinsonism and Related Disorders"},{"issue":"11","key":"10.1002\/14651858.CD009684.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/j.1468-1331.2008.02296.x","article-title":"Effects of zonisamide on isolated head tremor","volume":"15","author":"Song","year":"2008","journal-title":"European Journal of Neurology"},{"issue":"7454","key":"10.1002\/14651858.CD009684.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0009|cit9","first-page":"305","article-title":"The effectiveness of treatments for essential tremor","volume":"3","author":"Bain","year":"1997","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0010|cit10","first-page":"77","article-title":"Clinical measurement of tremor","volume":"13 Suppl 3","author":"Bain","year":"1998","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0011|cit11","first-page":"7","article-title":"Criteria for the diagnosis of essential tremor","volume":"54 Suppl 4","author":"Bain","year":"2000","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0012|cit12","first-page":"26","article-title":"Tremor assessment and quality of life measurements","volume":"54 Suppl 4","author":"Bain","year":"2000","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1212\/WNL.41.12.1982","article-title":"Is essential tremor benign?","volume":"41","author":"Busenbark","year":"1991","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD009684.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/mds.870120621","article-title":"Agreement among movement disorder specialists on the clinical diagnosis of essential tremor","volume":"12","author":"Chouinard","year":"1997","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0015|cit15","unstructured":"Deeks JJ Higgins JP Altman DG editor(s) Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0016|cit16","first-page":"2","article-title":"Consensus Statement of the Movement Disorder Society on Tremor","volume":"13 Suppl 3","author":"Deuschl","year":"1998","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0017|cit17","first-page":"1","article-title":"Essential tremor","volume":"54 Suppl 4","author":"Deuschl","year":"2000","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"13","key":"10.1002\/14651858.CD009684.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/mds.25648","article-title":"Task Force Report: scales for screening and evaluating tremor. Critique and recommendations","volume":"28","author":"Elble","year":"2013","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0020|cit20","first-page":"225","article-title":"Clinical rating scale for tremor","volume-title":"Parkinson's Disease and Movement Disorders","author":"Fahn","year":"1993"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0021|cit21","first-page":"1","article-title":"Definitions and behavioural classifications","volume-title":"Handbook of Tremor Disorders","author":"Findley","year":"1995"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0022|cit22","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2015"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/archneur.1982.00510240012003","article-title":"Prevalence of essential tremor: results from the Copiah county study","volume":"39","author":"Haerer","year":"1992","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0024|cit24","volume-title":"Managing clinically important drug interactions","author":"Hansten","year":"2004"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0026|cit26","unstructured":"Higgins JP Altman DG Sterne JAC editor(s) Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/mds.870110306","article-title":"A randomized, double-blind, placebo controlled study to evaluate botulinum toxin type A in essential tremor","volume":"11","author":"Jankovic","year":"1996","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/mds.10221","article-title":"Essential tremor: a heterogeneous disorder","volume":"17","author":"Jankovic","year":"2002","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1212\/WNL.36.7.1001","article-title":"Disability in essential tremor: effect of treatment","volume":"36","author":"Koller","year":"1986","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1212\/WNL.39.12.1587","article-title":"Acute and chronic effects of propranolol and primidone in essential tremor","volume":"39","author":"Koller","year":"1989","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0031|cit31","first-page":"5-S9; discussio","article-title":"Zonisamide: chemistry, mechanism of action, and pharmacokinetics","volume":"13 Suppl 1","author":"Leppik","year":"2004","journal-title":"Seizure"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0032|cit32","first-page":"339:b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"21","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1001\/archneur.55.6.823","article-title":"Diagnostic criteria for essential tremor","volume":"55","author":"Louis","year":"1998","journal-title":"Archives of Neurology"},{"issue":"12","key":"10.1002\/14651858.CD009684.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1056\/NEJMcp010928","article-title":"Clinical practice, essential tremor","volume":"342","author":"Louis","year":"2001","journal-title":"New England Medical Journal"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/1531-8257(200101)16:1<89::AID-MDS1001>3.0.CO;2-L","article-title":"A teaching videotape for the assessment of essential tremor","volume":"16","author":"Louis","year":"2001","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1474-4422(05)00991-9","article-title":"Essential tremor","volume":"4","author":"Louis","year":"2005","journal-title":"Lancet Neurology"},{"issue":"5","key":"10.1002\/14651858.CD009684.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/mds.22838","article-title":"How common is the most common movement disorder? Update on the worldwide prevalence of essential tremor","volume":"25","author":"Louis","year":"2010","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0168-0102(01)00298-X","article-title":"Zonisamide has beneficial effects on Parkinson's disease patients","volume":"41","author":"Murata","year":"2001","journal-title":"Neuroscience Research"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0039|cit39","first-page":"685","article-title":"Effect of zonisamide on resting tremor resistant to aniparkinsonian medication","volume":"55","author":"Nakanishi","year":"2003","journal-title":"No To Shinkei"},{"issue":"4","key":"10.1002\/14651858.CD009684.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/1531-8257(200007)15:4<678::AID-MDS1012>3.0.CO;2-0","article-title":"Gabapentin for essential tremor: a multiple-dose, double-blind, placebo-controlled trial","volume":"15","author":"Ondo","year":"2000","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1212\/01.wnl.0000200779.03748.0f","article-title":"Topiramate in essential tremor: A double-blind, placebo-controlled trial","volume":"66","author":"Ondo","year":"2006","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/mds.870130315","article-title":"Double-blind placebo-controlled study of gabapentin in essential tremor","volume":"13","author":"Pahwa","year":"1998","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1136\/jnnp.47.5.466","article-title":"Essential tremor in Rochester, Minnesota: a 45-year study","volume":"47","author":"Rajput","year":"1984","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0044|cit44","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1212\/WNL.44.1.61","article-title":"Prevalence of essential tremor: a door to-door survey in Terrasini, Sicily","volume":"44","author":"Salemi","year":"1994","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1002\/mds.22633","article-title":"Synchronized brain network associated with essential tremor as revealed by magnetoencephalography","volume":"24","author":"Schnitzler","year":"2009","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0047|cit47","doi-asserted-by":"crossref","DOI":"10.1002\/9780470753286","volume-title":"Handbook of Epilepsy Treatment","author":"Shorvon","year":"2005"},{"issue":"7146","key":"10.1002\/14651858.CD009684.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1719-1720","DOI":"10.1136\/bmj.316.7146.1719","article-title":"Understanding controlled trials: Crossover trials","volume":"316","author":"Sibbald","year":"1998","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0049|cit49","first-page":"418","article-title":"A community survey of Parkinson's disease","volume":"141","author":"Snow","year":"1989","journal-title":"Canadian Medical Association Journal"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/mds.21412","article-title":"Assessment of interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor","volume":"22","author":"Stacy","year":"2007","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0051|cit51","volume-title":"Essential Tremor Epidemiology, Diagnosis and Treatment","author":"Sullivan","year":"2004"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0052|cit52","first-page":"90","article-title":"Pharmacologic treatment of tremor","volume":"13 Suppl 3","author":"Wasielewski","year":"1998","journal-title":"Movement Disorders"},{"issue":"3","key":"10.1002\/14651858.CD009684.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s00415-012-6628-x","article-title":"Treatment of essential tremor: a systematic review of evidence and recommendations from the Italian Movement Disorders Association Essential Tremor Committee","volume":"260","author":"Zappia","year":"2013","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s11910-002-0008-3","article-title":"Management of essential tremor","volume":"2","author":"Zesiewicz","year":"2002","journal-title":"Current Neurology and Neuorscience Reports"},{"issue":"12","key":"10.1002\/14651858.CD009684.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1212\/01.WNL.0000163769.28552.CD","article-title":"Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"64","author":"Zesiewicz","year":"2005","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD009684.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/mds.21282","article-title":"A double-blind placebo-controlled trial of zonisamide (Zonegran) in the treatment of essential tremor","volume":"22","author":"Zesiewicz","year":"2007","journal-title":"Movement Disorders"},{"issue":"19","key":"10.1002\/14651858.CD009684.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1212\/WNL.0b013e318236f0fd","article-title":"Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards subcommittee of the American Academy of Neurology","volume":"77","author":"Zesiewicz","year":"2011","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD009684.pub2-BIB0058|cit58","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009684","article-title":"Zonisamide for essential tremor","author":"Bruno","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD009684.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T03:02:36Z","timestamp":1651719756000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009684.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Movement Disorders Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,8,24]]},"references-count":58,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009684.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,24]]}}}